|
1
|
Mozaffarian D, Benjamin EJ, Go AS, Anett
DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ,
Howard VJ, et al: Heart disease and stroke statistics-2015 update:
A report from the American Heart Association. Circulation.
131:e29–e322. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jennings RB, Sommers HM, Smyth GA, Flack
HA and Linn H: Myocardial necrosis induced by temporary occlusion
of a coronary artery in the dog. Arch Pathol. 70:68–78.
1960.PubMed/NCBI
|
|
3
|
Turer AT and Hill JA: Pathogenesis of
myocardial ischemia-reperfusion injury and rationale for therapy.
Am J Cardiol. 106:360–368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Z, Wu G, Liu H, Xing N, Sun Y, Zhai
Y, Yang B, Kong AT, Kuang H and Wang Q: Cardioprotective effect of
the xanthones from Gentianella acuta against myocardial
ischemia/reperfusion injury in isolated rat heart. Biomed
Pharmacother. 93:626–635. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rothmeier AS and Ruf W: Protease-activated
receptor 2 signaling in inflammation. Semin Immunopathol.
34:133–149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Steinberg SF: The cardiovascular actions
of protease-activated receptors. Mol Pharmacol. 67:2–11. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Murray DB, McLarty-Williams J, Nagalla KT
and Janicki JS: Tryptase activates isolated adult cardiac
fibroblasts via protease activated receptor-2 (PAR-2). J Cell
Commun Signal. 6:45–51. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Morris DR, Ding Y, Ricks TK, Gullapalli A,
Wolfe BL and Trejo J: Protease-activated receptor-2 is essential
for factor VIIa and Xa-induced signaling, migration, and invasion
of breast cancer cells. Cancer Res. 66:307–314. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Adams MN, Ramachandran R, Yau MK, Suen JY,
Fairlie DP, Hollenberg MD and Hooper JD: Structure, function and
pathophysiology of protease activated receptors. Pharmacol Ther.
130:248–282. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yau MK, Liu L and Fairlie DP: Toward drugs
for protease- activated receptor 2 (PAR2). J Med Chem.
56:7477–7497. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bohm SK, Kong W, Bromme D, Smeekens SP,
Anderson DC, Connolly A, Kahn M, Nelken NA, Coughlin SR, Payan DG
and Bunnett NW: Molecular cloning, expression and potential
functions of the human proteinase-activated receptor-2. Biochem J.
314:1009–1016. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kanke T, Macfarlane SR, Seatter MJ,
Davenport E, Paul A, McKenzie RC and Plevin R: Proteinase-activated
receptor-2-mediated activation of stress-activated protein kinases
and inhibitory kappa B kinases in NCTC 2544 keratinocytes. J Biol
Chem. 276:31657–31666. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tong XH, Ding JW, Yang J, Liu CQ, Zhang Y,
Li S, Li WH and Li L: The effect of protease-activated receptor 2
on rat apoptotic cardiomyocytes underwent ischemia reperfusion
injury. Zhonghua xin xue guan bing za zhi (Chinese). 37:832–836.
2009.
|
|
14
|
Antoniak S, Rojas M, Spring D, Bullard TA,
Verrier ED, Blaxall BC, Mackman N and Pawlinski R:
Protease-activated receptor 2 deficiency reduces cardiac
ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol.
30:2136–2142. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rueden CT, Schindelin J, Hiner MC, DeZonia
BE, Walter AE, Arena ET and Eliceiri KW: ImageJ2: ImageJ for the
next generation of scientific image data. BMC Bioinformatics.
18:5292017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Odashima M, Usui S, Takagi H, Hong C, Liu
J, Yokota M and Sadoshima J: Inhibition of endogenous Mst1 prevents
apoptosis and cardiac dysfunction without affecting cardiac
hypertrophy after myocardial infarction. Circ Res. 100:1344–1352.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen PJ, Shang AQ, Yang JP and Wang WW:
microRNA-874 inhibition targeting STAT3 protects the heart from
ischemia-reperfusion injury by attenuating cardiomyocyte apoptosis
in a mouse model. J Cell Physiol. 234:6182–6193. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bunck AC, Engelen MA, Schnackenburg B,
Furkert J, Bremer C, Heindel W, Stypmann J and Maintz D:
Feasibility of functional cardiac MR imaging in mice using a
clinical 3 Tesla whole body scanner. Invest Radiol. 44:749–756.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mußbach F, Ungefroren H, Günther B,
Katenkamp K, Henklein P, Westermann M, Settmacher U, Lenk L, Sebens
S, Müller JP, et al: Proteinase-activated receptor 2 (PAR2) in
hepatic stellate cells-evidence for a role in hepatocellular
carcinoma growth in vivo. Mol Cancer. 15:542016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gu J, Fan Y, Liu X, Zhou L, Cheng J, Cai R
and Xue S: SENP1 protects against myocardial ischaemia/reperfusion
injury via a HIF1 α-dependent pathway. Cardiovasc Res. 104:83–92.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liang S, Aiqun M, Figtree G and Ping Z:
GAPDH-silence preserves H9C2 cells from acute hypoxia and
reoxygenation injury. Int J Biol Macromol. 81:375–386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iablokov V, Hirota CL, Peplowski MA,
Ramachandran R, Mihara K, Hollenberg MD and MacNaughton WK:
Proteinase- activated receptor 2 (PAR2) decreases apoptosis in
colonic epithelial cells. J Biol Chem. 289:34366–34377. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li W, Liu Y, Wang B, Luo Y, Hu N, Chen D,
Zhang X and Xiong Y: Protective effect of berberine against
oxidative stress-induced apoptosis in rat bone marrow-derived
mesenchymal stem cells. Exp Ther Med. 12:4041–4048. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dong Q, Li J, Wu QF, Zhao N, Qian C, Ding
D, Wang BB, Chen L, Guo KF, Fu D, et al: Blockage of transient
receptor potential vanilloid 4 alleviates myocardial
ischemia/reperfusion injury in mice. Sci Rep. 7:426782017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Meng X, Song W, Deng B, Xing Z and Zhang
W: 3-aminobenzamide, one of poly(ADP-ribose)polymerase-1
inhibitors, rescuesapoptosisin rat models of spinal cord injury.
Int J Clin Exp Pathol. 8:12207–12215. 2015.PubMed/NCBI
|
|
26
|
Badr R, Hashemi M, Javadi G, Movafagh A
and Mahdian R: Assessment of global ischemic/reperfusion and
Tacrolimus administration on CA1 region of hippocampus: Gene
expression profiles of BAX and BCL2 genes. Bratisl Lek Listy.
117:358–362. 2016.PubMed/NCBI
|
|
27
|
Sabri A, Muske G, Zhang H, Pak E, Darrow
A, Andrade- Gordon P and Steinberg SF: Signaling properties and
functions of two distinct cardiomyocyte protease-activated
receptors. Circ Res. 86:1054–1061. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Darmoul D, Gratio V, Devaud H and Laburthe
M: Protease- activated receptor 2 in colon cancer: Trypsin-induced
MAPK phosphorylation and cell proliferation are mediated by
epidermal growth factor receptor transactivation. J Biol Chem.
279:20927–20934. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Katritch V, Cherezov V and Stevens RC:
Structure-function of the G protein-coupled receptor superfamily.
Annu Rev Pharmacol Toxicol. 53:531–556. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang R, Zatta A, Kin H, Wang N, Reeves
JG, Mykytenko J, Deneve J, Zhao ZQ, Guyton RA and Vinten-Johansen
J: PAR-2 activation at the time of reperfusion salvages myocardium
via an ERK1/2 pathway in in vivo rat hearts. Am J Physiol Heart
Circ Physiol. 293:H2845–H2852. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Antoniak S, Sparkenbaugh EM, Tencati M,
Rojas M, Mackman N and Pawlinski R: Protease activated receptor-2
contributes to heart failure. PLoS One. 8:e817332013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu D, Li M, Tian Y, Liu J and Shang J:
Luteolin inhibits ROS-activated MAPK pathway in myocardial
ischemia/reperfusion injury. Life Sci. 122:15–25. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Portbury AL, Ronnebaum SM, Zungu M,
Patterson C and Willis MS: Back to your heart: Ubiquitin proteasome
system-regulated signal transduction. J Mol Cell Cardiol.
52:526–537. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun L, Fan H, Yang L, Shi L and Liu Y:
Tyrosol prevents ischemia/reperfusion-induced cardiac injury in
H9c2 cells: Involvement of ROS, Hsp70, JNK and ERK, and apoptosis.
Molecules. 20:3758–3775. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim YK, Kim HJ, Kwon CH, Kim JH, Woo JS,
Jung JS and Kim JM: Role of ERK activation in cisplatin-induced
apoptosis in OK renal epithelial cells. J Appl Toxicol. 25:374–382.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schafer C and Williams JA: Stress kinases
and heat shock proteins in the pancreas: Possible roles in normal
function and disease. J Gastroenterol. 35:1–9. 2000.PubMed/NCBI
|
|
37
|
Napoli C, Cicala C, Wallace JL, de Nigris
F, Santagada V, Caliendo G, Franconi F, Ignarro LJ and Cirino G:
Protease-activated receptor-2 modulates myocardial
ischemia-reperfusion injury in the rat heart. Proc Natl Acad Sci
USA. 97:3678–3683. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schmidlin F, Amadesi S, Dabbagh K, Lewis
DE, Knott P, Bunnett NW, Gater PR, Geppetti P, Bertrand C and
Stevens ME: Protease-activated receptor 2 mediates eosinophil
infiltration and hyperreactivity in allergic inflammation of the
airway. J Immunol. 169:5315–5321. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ferrell WR, Lockhart JC, Kelso EB, Dunning
L, Plevin R, Meek SE, Smith AJ, Hunter GD, McLean JS, McGarry F, et
al: Essential role for proteinase-activated receptor-2 in
arthritis. J Clin Invest. 111:35–41. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
McLean PG, Aston D, Sarkar D and Ahluwalia
A: Protease- activated receptor-2 activation causes EDHF-like
coronary vasodilation: Selective preservation in
ischemia/reperfusion injury: Involvement of lipoxygenase products,
VR1 receptors, and C-fibers. Circ Res. 90:465–472. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Boyd JH, Mathur S, Wang Y, Bateman RM and
Walley KR: Toll-like receptor stimulation in cardiomyoctes
decreases contractility and initiates an NF-kappaB dependent
inflammatory response. Cardiovasc Res. 72:384–393. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Soh UJ, Dores MR, Chen B and Trejo J:
Signal transduction by protease-activated receptors. Br J
Pharmacol. 160:191–203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Freedman NJ and Shenoy SK: Regulation of
inflammation by β-arrestins: Not just receptor tales. Cell Signal.
41:41–45. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Patel PA, Tilley DG and Rockman HA:
Physiologic and cardiac roles of beta-arrestins. J Mol Cell
Cardiol. 46:300–308. 2009. View Article : Google Scholar : PubMed/NCBI
|
